Chronic total occlusion
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with a confirmed diagnosis of CTO via coronary angiography who have undergone PCI treatment; 2. Patients aged 18 = age < 80 years, regardless of gender; 3. Patients who can understand the purpose of the study, voluntarily participate, sign the informed consent form, and agree to complete clinical follow-up in accordance with the study requirements.
Exclusion criteria
Exclusion criteria: 1. Patients who have experienced cerebrovascular events (such as cerebral hemorrhage, cerebral embolism, etc.) within 3 months; 2. Patients with New York Heart Association (NYHA) Class IV cardiac function and/or complicated with acute left heart failure; 3. Patients with end-stage renal disease requiring dialysis; 4. Patients with obvious active bleeding; 5. Patients with severe arrhythmias (such as sick sinus syndrome, second-degree type II or third-degree atrioventricular block, etc.); 6. Patients with an expected lifespan of less than 12 months; 7. Patients with significantly limited exercise capacity (especially those with musculoskeletal diseases, vestibular dysfunction, etc.) who are unable to complete low-intensity exercises (such as bedside standing, passive joint movements, etc.); 8. Patients who were rehospitalized for repeated illness and underwent PCI treatment again; 9. Patients who conduct long-term and regular exercise training through participation in communities, associations, training courses, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of life;Coronary microcirculatory function; | — |
Secondary
| Measure | Time frame |
|---|---|
| Cardiac function;Level of exercise fear; | — |
Countries
China
Contacts
No.980 Hospital of PLA Joint Logistics Support Force